Assessment of the appropriateness of extemporaneous preparations prescribed in Swedish primary care

International Journal of Pharmacy Practice

Volumn 4, Issue 2, 1996, Pages 117-122

  Lindblad, Åsa Kettis ^a   Isacson, Dag ^a   Eriksson, Carin ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETANILIDE; ACETYLSALICYLIC ACID; BELLADONNA ALKALOID; BORIC ACID; CAFFEINE; CALCIUM CARBONATE; CAMPHOR; CARBACHOL; COAL TAR; CRYSTAL VIOLET; DICYCLOVERINE; DIPHENHYDRAMINE; DITHRANOL; EPHEDRINE; ETHYLMORPHINE; HYDROCORTISONE; ICHTHAMMOL; MERBROMIN; METHAMPHETAMINE; PERMANGANATE POTASSIUM; PHENAZONE; PILOCARPINE; PROPYLENE GLYCOL; RESORCINOL; SALICYLIC ACID; SILVER NITRATE; UREA;

ARTICLE; COLIC; CONJUNCTIVITIS; COUGHING; DRUG CHOICE; ECZEMA; EYE DISEASE; GASTROINTESTINAL DISEASE; GLAUCOMA; HUMAN; NEUROLOGIC DISEASE; OSTEOPOROSIS; PHARMACEUTICS; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSORIASIS; RESPIRATORY TRACT DISEASE; RHINITIS; SWEDEN; TINEA VERSICOLOR;

EID: 0029886830     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7174.1996.tb00852.x     Document Type: Article

References (24)

1. Nilsson JLG, Gunnarsson B. Orphan drugs in Sweden need better documentation and clearer legislation. (Published in Swedish.) Läkartidningen 1986;83:3829-30.
2. Nightingale SL. Orphan drugs. Am Fam Physician 1986;33:235-6.
3. Kettis Lindblad A, Isacson D. Factors associated with the prescribing of extemporaneous preparations in Sweden. Int J Pharm Pract 1995;3:91-6.
4. Nordic Council on Medicines. Nordic drug index with classification and defined daily doses. 3rd ed. Uppsala: Nordic Council on Medicines, 1985.
5. Reynolds JEF, editor. Martindale: The Extra Pharmacopoeia. 29th ed. London: The Pharmaceutical Press, 1989.
6. Norris J, editor. Professional guide to drugs. Springhouse: Intermed Communications, 1982.
7. The Swedish therapy handbook 1987/88. 6th ed. (Published in Swedish). Stockholm: Apoteksbolaget AB, 1987.
8. Rorsman H, Björnberg A. Dermatology venereology. 4th ed. (Published in Swedish.) Lund: Studentlitteratur, 1987.
9. Mårdh PA. Infections in primary care. 1st ed. (Published in Swedish.) Falköping: Almqvist & Wiksell, 1986.
10. Pharmaceutical specialities in Sweden. 22nd ed. (Published in Swedish). Kungsbacka: Läkemedelsinformation AB, 1987.
11. Pharmaceutical specialities in Sweden. 23rd ed. (Published in Swedish.) Kungsbacka: Läkemedelsinformation AB, 1988.
12. Non-pharmaceutical products in pharmacies. (Published in Swedish.) Stockholm: Apoteksbolaget AB, 1987.
13. Bialonczyk C, Partsch H, Donner A. Lead poisoning following long-term application of diachylon ointment. (Published in German). Z Hautkrankheiten 1989;64:1118-20.
14. Dicyclomine hydrochloride for the treatment of infant colic - safe medication? (Published in Swedish.) In: Information from the Pharmaceutical Division at the Swedish National Board of Health and Welfare 1985;10(6):1-2.
15. Hwang CP, Danielsson B. Dicyclomine hydrochloride in infantile colic. Br Med J 1985;291:1014.
16. Illingworth RS. Infantile colic revisited. Arch Dis Child 1985;60:981-5.
17. Nakayama H, Shono M, Hada S. Mercury exanthem. J Am Acad Dermatol 1984;11:137-9.
18. Aberer W. Reply. Bull Am Acad Dermatol 1991;25:1097-8.
19. Lead poisoning adverse effect of ointment treatment of skin disease. (Published in Swedish.) In: Information from the Swedish Medical Products Agency. 1994;5:216.
20. Gloor M. On extemporaneous compounding in modern dermatological therapy. (Published in German.) Pharm Z 1986;131(3):89-95.
21. Araujo OE, DeSantis DA, Doering PL. Survey of the professional interrelations between dermatologist and pharmacist. Drug Intell Clin Pharm 1986;20:876-80.
22. Kanis JA, Meunier J. Should we use fluoride to treat osteoporosis?: a review. Q J Med 1984;NS53:145-64.
23. Silverman HI. The right to compound? [letter]. Am Pharm 1990;NS30(9):8.
24. Santopadre G. Disagreement [letter]. Am Pharm Ibid 1990;NS30(9):8.